GAN-CAN

Pharma

Nerve pain compound for cancer patients gets FDA fast-track for DARA

DARA BioSciences‘s (NASDAQ:DARA) investigational pain treatment for cancer patients now has fast-track status from the U.S. Food and Drug Administration. The compound KRN5500 is being developed with the National Cancer Institute to treat neuropathic pain brought on by chemotherapy. The FDA’s fast-track program is intended to facilitate development and speed regulatory review of new drugs […]

Pharma

Human antibody company Immunologix starts raising $1.1 million

South Carolina biotech company Immunologix has raised nearly $250,000 in a financing round targeting $1.1 million, according to securities filings. Charleston, South Carolina-based Immunologix has developed technology that produces human antibodies that can target bacteria, viruses and even cancer. The company is now raising money again after bringing in just over $1 million in equity […]

presented by
Pharma

Cardinal Health opens molecular imaging center in Arizona

Pharmaceuticals distributor Cardinal Health (NYSE: CAH) has opened a molecular imaging center with the goal of developing new radioactive imaging agents that will  help doctors treat a wide range of diseases like cancer, heart disease and neurological disorders. Cardinal scientists, engineers and manufacturing experts will work with clients in the pharmaceutical and academic research industries […]

News

Why the Alaina Giordano case should worry the healthcare industry

Cancer is a lot of things. But it’s not the reason Alaina Giordano’s children may wind up living with their father. If Giordano’s name doesn’t immediately ring any bells in the medical community, her case should. Giordano is the Durham, North Carolina, mom with breast cancer embroiled in a custody dispute with her estranged husband, […]

MedCity Influencers

Are expensive cancer drugs worth the cost to Medicare?

The health care cost debate takes place on two stages using two languages, one scientific, the other economic. The net result is a failure to communicate. The scientific texts emanated over the weekend from the American Society of Clinical Oncology meeting in Chicago. Ongoing clinical trials showed that science has come up with new drugs […]

Pharma

FDA’s REMS program puts BDSI at a disadvantage in cancer drug market

Commercializing a new drug in the face of strict U.S. Food and Drug Administration guidelines is tough. It’s even tougher when direct competitors don’t have those same limits. That’s the situation facing Raleigh, North Carolina-based BioDelivery Sciences International (NASDAQ:BDSI). A cancer patient seeking relief from breakthrough cancer pain would be able to fill a prescription […]

News

Sex supplement helps cancer survivors, Wake Forest researchers find

Wake Forest University researchers have found that a product available for the last decade as a sexual aid may have the added benefit of helping female cancer survivors alleviate their post-cancer symptoms. ArginMax, a product of Hawaii firm the Daily Wellness Company, was originally developed as a natural nutritional supplement to enhance sexual performance for […]